Characteristics | N = 21 (%) |
---|---|
Gender (n, %) | |
Male | 6 (29%) |
Female | 15 (71%) |
Age in years, mean (SD, range) | 64 (11.2, 40–80) |
Recruitment site (n, %) | |
The University of Tokyo Hospital | 11 (52%) |
Kansai Medical University Hospital | 10 (48%) |
Primary lesion (n, %) | |
Breast | 10 (48%) |
Lung | 7 (33%) |
Pancreatic | 3 (14%) |
Esophageal | 1 (5%) |
Progression (n, %) | |
Localized | 3 (14%) |
Metastatic | 18 (86%) |
ECOG Performance Status (n, %) | |
Grade 0 | 9 (43%) |
Grade 1 | 8 (38%) |
Grade 2 | 2 (10%) |
Grade 3 | 2 (10%) |
Treatment modality (n, %) | |
Chemotherapy | 20 (95%) |
Hormone therapy | 1 (5%) |
Treatment time (n, %) | |
within 1 month | 19 (90%) |
1–3 months prior | 1 (5%) |
12 months prior | 1 (5%) |
Employment (n, %) | |
Employed | 3 (14%) |
Housewife | 10 (48%) |
Unemployed | 6 (29%) |
Others | 2 (10%) |
Education | |
Junior high school | 7 (33%) |
High school | 5 (24%) |
Junior college | 6 (29%) |
Undergraduate/postgraduate | 3 (14%) |
Questionnairea completion time in minutes, mean (SD, range) | 30 (11.5, 15–58) |